The stock of Stevanato Group S.p.A. (NYSE:STVN) last traded at $15.00, unchanged from the previous session.
Data from the available sources indicates that Stevanato Group S.p.A. (NYSE:STVN) is covered by 8 analysts. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $25.83 and a low of $15.70, we find $20.86. Given the previous closing price of $15.00, this indicates a potential upside of 39.07 percent. STVN stock price is now -12.24% away from the 50-day moving average and -10.71% away from the 200-day moving average. The market capitalization of the company currently stands at $4.32B.
In total, 1 analysts have assigned it a hold rating, and 7 have given it a buy rating. Brokers who have rated the stock have averaged $20.52 as their price target over the next twelve months.
With the price target of $24, Wells Fargo recently initiated with Overweight rating for Stevanato Group S.p.A. (NYSE: STVN). On August 10, 2021, Morgan Stanley recently initiated its ‘Overweight’ rating on the stock quoting a target price of $26, while ‘KeyBanc Capital Markets’ rates the stock as ‘Overweight’.
A total of 2.99% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in STVN stock. A new stake in Stevanato Group S.p.A. shares was purchased by COPELAND CAPITAL MANAGEMENT, LLC during the first quarter worth $21,197,000. DYNAMO INTERNACIONAL GESTAO DE RECURSOS LTDA. invested $5,127,000 in shares of STVN during the first quarter. In the first quarter, PEMBROKE MANAGEMENT, LTD acquired a new stake in Stevanato Group S.p.A. valued at approximately $4,520,000. NORTHERN TRUST CORP acquired a new stake in STVN for approximately $1,053,000. STIFEL FINANCIAL CORP purchased a new stake in STVN valued at around $982,000 in the second quarter.
With an opening price of $15.22 on Tuesday morning, Stevanato Group S.p.A. (NYSE: STVN) set off the trading day. During the past 12 months, Stevanato Group S.p.A. has had a low of $13.35 and a high of $24.60. As of last week, the company has a debt-to-equity ratio of 0.25, a current ratio of 2.10, and a quick ratio of 1.60. The fifty day moving average price for STVN is $17.09 and a two-hundred day moving average price translates $16.80 for the stock.
The latest earnings results from Stevanato Group S.p.A. (NYSE: STVN) was released for Jun, 2022. According to the Medical Instruments & Supplies Company, earnings per share came in at $0.12, beating analysts’ expectations of $0.11 by 0.01. This compares to $0.08 EPS in the same period last year. The net profit margin was 13.60% and return on equity was 14.20% for STVN. The company reported revenue of $247.03 million for the quarter, compared to $252.98 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -2.35 percent. For the current quarter, analysts expect STVN to generate $247.93M in revenue.
Stevanato Group S.p.A.(STVN) Company Profile
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for pharma and healthcare. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. operates as a subsidiary of Stevanato Holding S.R.L.